Back

Coronary inflammation as assessed by pericoronary adipose tissue (PCAT) attenuation in patients with and without standard modifiable cardiovascular risk factors (SMuRFs)

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Imaging in cardiovascular risk assessment (2) Imaging ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Mr Seiyon Sivakumar

Melbourne (Australia)

7 More presentations in this session

Presentation thumbnail
Linking exercise-induced ventricular ectopy with subclinical myocardial damage in asymptomatic individuals
Professor U. Yuksel (Ankara, TR)
Abstract Slides Video
Presentation thumbnail
Higher disease activity and quality of life impairment are associated with increased carotid plaque in psoriatic arthritis patients
Doctor O. Garza Flores (Monterrey, MX)
Abstract Slides Video
Presentation thumbnail
Impact of the peri coronary artery inflammation and Ai based risk predictors using cardiac CTA on the stratification of patients with suspected CAD Insight from the NHS England Chest Pain Pilot
Miss N. Sanfeliu Garces (Milton Keynes, GB)
Abstract Slides Video
Presentation thumbnail
Utility of non-invasive MRI assessment of tenosynovial amyloidosis for early detection of cardiac amyloidosis: UNRAVEL, a pilot study
Mr M. Saldanha (Montreal, CA)
Abstract Slides Video
Presentation thumbnail
Imaging-guided lipid-lowering therapy in rheumatology patients at cardiovascular risk
Mr B. Pashaee (Philadelphia, US)
Abstract Slides Video

Access the full session

Session thumbnail
Imaging in cardiovascular risk assessment (2)

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Session
Inflammation and coronary artery disease: from diagnosis to management
thumbnail
Congress Presentation
Coronary and systemic inflammation: the ORFAN study
thumbnail
Congress Presentation
Clinical outcomes of patients undergoing percutaneous coronary intervention for coronary artery disease without standard modifiable cardiovascular risk factors according to clinical presentation

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources